Areas include health research across life stages, from paediatrics to health ageing and resilience
The University of Liverpool and McMaster University have announced an institutional strategic partnership, offering £300,000 in seed funding to nine selected projects to support the development of collaborations in key areas of research.
The areas of research include health research across life stages, from paediatrics to healthy ageing and resilience, along with social sciences, humanities and research, as well as development in port-related activities.
The projects selected were announced by McMaster at a celebratory event with representatives from the University of Liverpool in attendance.
The three health research projects selected focus on innovative antibiotic discovery to combat invasive Salmonella in Africa, engineering perfusable vascular organoids for ageing and chronic disease studies and developing pharmacogenetic polygenic risk scores using machine learning methods.
David Farrar, president, McMaster, commented: “We’re proud to partner with the University of Liverpool to fund cutting-edge, collaborative research and foster knowledge exchange among our students and faculty.
“This first round of funding recipients includes a diverse range of experts who will advance research that supports knowledge creation and health and well-being in Canada, the UK and beyond.”
The new funding is the latest in a series of collaborative initiatives between McMaster and the University of Liverpool that aim to advance the institution’s mission of accelerating impact in research and education.
In June 2022, McMaster and the University of Liverpool entered into a partnership to advance pandemic preparedness research and training opportunities at both institutions.
Ferrar explained that both universities intend to take on “opportunities to accelerate vaccine and antibiotic development” while addressing other “challenges related to infrastructure, PPE, manufacturing, public policy and the spread of misinformation”.
Earlier this year, in March, the University of Liverpool announced that it would be leading the Relativistic Ultrafast Electron Diffraction and Imaging facility worth £125m to drive scientific discovery and advance technologies.
Most recently, in April, McMaster partnered with King’s College London’s Biomedical Engineering and Imaging Sciences to support the discovery and development of new health interventions for nuclear medicine research and education.
